Synthetic resins or natural rubbers -- part of the class 520 ser – Synthetic resins – Polymers from only ethylenic monomers or processes of...
Patent
1997-06-25
1998-10-13
Schofer, Joseph L.
Synthetic resins or natural rubbers -- part of the class 520 ser
Synthetic resins
Polymers from only ethylenic monomers or processes of...
5263031, 526304, 526266, C08F 2400, C08F22056, C08F22058
Patent
active
058213120
ABSTRACT:
The present invention includes polymerizable monomers comprising an acid-functionalized glycoside moiety. The monomer can have a polymerizable functional group, such as an olefinic bond, to which the acid-functionalized glycoside moiety is attached by a spacer group, for example, an alkylene group, or an alkylene group wherein one or more carbon atoms are substituted by heteroatoms, such as oxygen, nitrogen or sulfur atoms. The present invention also includes polymers comprising pendant acid-functionalized glycoside moieties. The present invention also provides a method for treating a microbial infection in a mammal by administering to the mammal a therapeutically effective amount of a polymer comprising one or more acid-functionalized glycoside moieties.
REFERENCES:
patent: 4721760 (1988-01-01), Graafland
patent: 4868289 (1989-09-01), Magnusson et al.
patent: 5034516 (1991-07-01), Roy et al.
Nakaya, T., et al., "Polymeric glycolipid analogues, 3.sup.a), Polymethacrylates containing glucose moieties attached to the polymer backbones via n-alkyl chains of various length," Makromol. Chem., Rapid Commun., 14:77-83 (1993).
Roy, R., et al., "Synthesis of Antigenic Carbohydrate Polymers Recognized by Lectins and Antibodies," J. Chem. Soc., Chem. Commun., pp. 1058-1060 (1988).
Mammen, M., et al., "Effective Inhibitors of Hemagglutination by Influenza Virus Synthesized from Polymers Having Active Ester Groups. Insight into Mechanism of Inhibition," J. Med. Chem., 38:4179-4190 (1995).
Itoh, M., et al., "Suppression of Influenza Virus Infection by an N-Thioacetylneuraminic Acid Acrylamide Copolymer Resistant to Neuraminidase," Virology, 212:340-347 (1995).
Matrosovich, M.N., "Towards the development of antimicrobial drugs acting by inhibition of pathogen attachment to host cells: a need for polyvalency," FEBS. LET, 252(1,2):1-4 (1989).
Sparks, M.A. et al., "Neuraminidase-Resistant Hemagglutination Inhibitors: Acrylamide Copolymers Containing a C-Glycoside of N-Acetylneuraminic Acid," J. of Med. Chem., 36(6):778-783 (1993).
Spaltenstein, A. and Whitesides, G.M., "Polyacrylamides Bearing Pendant .alpha.-Sialoside Groups Strongly Inhibit Agglutination of Erythrocytes by Influenza Virus," J. Am. Chem. Soc., 113:686-687 (1991).
Kingery-Wood, J.E. et al., "The Agglutination of Erythrocytes by Influenza Virus is Strongly Inhibited by Liposomes Incorporating an Analog of Sialyl Gangliosides," J. Am. Chem. Soc., 114(18):7303-7305 (1992).
Matrosovich, M.N. et al., "Synthetic polymeric sialoside inhibitors of influenza virus receptor-binding activity," FEBS LETTERS 272(1,2):209-212 (Oct. 1990).
Byramova, N.E. et al., "Synthesis of Sialic Acid Pseudopolysaccharides by Coupling of Spacer-Connected Neu5Ac With Activated Polymer," J. Carbohydrate Chem., 10(4):691-700 (1991).
Glass, R.I. et al., "Rotavirus Vaccines: Success by Reassortment?," Science, 265:1389-1391 (Sep. 1994).
Blacklow, N.R. and Greenberg, H.B., "Viral Gastroenteritis," N. En. J. Med., 325:252-264 (Jul. 1991).
LeBaron, C.W. et al., "Annual Rotavirus Epidemic Patterns in North America," J. Am. Med. Assoc., 264:983-988 (Aug. 1990).
Yolken, R.H. et al., "Sialic Acid Glycoproteins Inhibit In Vitro and In Vivo Replication of Rotaviruses," J. Clin. Invest., 79:148-154 (Jan. 1987).
Kiefel, M.J. et al., "Synthesis and Biological Evaluation of N-Acetylneuraminic Acid-Based Rotavirus Inhibitors," J. Med. Chem. 39:1314-1320 (1996).
Yuen, C.-T. et al., "Novel Sulfated Ligands for the Cell Adhesion Molecule E-Selection Revealed by the Neoglycolipid Technology Among O-Linked Oligosaccharides on an Ovarian Cystadenoma Glycoprotein," Biochemistry 31:9126-9131 (1992).
Roy, R. et al., "Solid-phase Synthesis of Dendritic Sialoside Inhibitors of Influenza A Virus Haemagglutinin," J. Chem. Soc., Chem. Commun.:1869-1872 (1993).
Sigal, G.B. et al., "Polyacrylamides Bearing Pendant .alpha.-Sialoside Groups Strongly Inhibit Agglutination of Erythrocytes by Influenza Virus: The Strong Inhibition Reflects Enhanced Binding Through Cooperative Polyvalent Interactions," J. Am. Chem. Society, 118(6):3789-3800 (Apr. 1996).
Jain, R.K. et al., "Total Synthesis of 3'-O-Sialyl, 6'-O-Sulfo Lewis.sup.x, NeuAca2.fwdarw. 3(6-O-SO.sub.3 Na)Gal.beta.1.fwdarw.4(Fuc.alpha.1.fwdarw.)-GlcNAc.beta.-OMe: A Major Capping Group of GLYCAM-I," J. Am. Chem. Soc., 116:12123-12124 (1994).
Lamblin, G. et al., "Structure of two sulphated oligosaccharides from respiratory mucins of a patient suffering from cystic fibrosis," Biochem. J., 275:199-206 (1991).
Lubineau, A. and Lemoine, R., "Regioselective Sulfation of Galactose Derivatives Through the Stannylene Procedure. New Synthesis of the 3'-O-Sulfated Lewis.sup.a Trisaccharide," Tetrahedron Letters, 35 (47):8795-8796 (1994).
Chandrasekaran, E.V. et al., "Ovarian Cancer .alpha.1,3-L-Fucosyltransferase," The J. of Biological Chem., 267(33):23806-23814 (Nov. 25, 1992).
Reddy, G.V. et al., "Synthesis of Precursors For the Dimeric 3-O-SO.sub.3 Na Lewis X and Lewis A Structures," Carbohydrate Research, 280:261-276 (1996).
Ohmoto, H., et al., "Studies on Selectin Blocker. 1. Structure-Activity Relationships of Sialyl Lewis X Analogs," J. Med. Chem., 39:1339-1343 (1996).
Geyer, H. et al., "Oligosaccharide Pattern of HIV-2 gp120; Dependence on Host Cells and Virus Isolates," Complex Carbohydrates in Biology and Medicine, Abstract U104: p. 266.
Haynes, P.A. and Cross, G.A.M., "Studies On The Structure And Function Of A Novel Carbohydrate Antigen Of Trypanosoma Cruzi," Complex Carbohydrates in Biology and Medicine, Abstract U105: p. 266.
Oda, Y. et al., "Structure-Function Studies On Carbohydrate Ligands Of Three Selectins. Modifications To Fucose, Sialic Acid And Sulfate As A Sialic Acid Replacement," Complex Carbohydrates in Biology and Medicine, Abstract U106: p. 266.
Linn, P. et al., "Site Specific Chemical Modification Of A Strep-Tococcal Antibody Binding Site," Complex Carbohydrates in Biology and Medicine, Abstract U107:p.266.
Guilbert, B. et al., "Dibutylstannylene Acetals: Useful Intermediates for the Regioselective Sulfation of Glycosides," Tetrahedron: Asymmetry, 5(11):2163-2178 (1994).
Ragan, J.A. and Cooper, K., "Synthesis Of A Galactose-Fucose Disaccharide Mimic of Sialyl Lewis X," Biorganic & Medicinal Chemistry Letters, 4(21):2563-2566 (1994).
Garigapati Venkata R.
Mandeville, III W. Harry
Cheng Wu C.
GelTex Pharmaceuticals Inc.
Schofer Joseph L.
LandOfFree
Acid-functionalized saccharides as polyvalent anti-infectives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acid-functionalized saccharides as polyvalent anti-infectives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acid-functionalized saccharides as polyvalent anti-infectives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-313921